Iron Overload in a Pregnant Woman with Thalassemia
Author Information
Author(s): Farmaki Kallistheni, Gotsis Efstathios, Tzoumari Ioanna, Berdoukas Vasilios
Primary Institution: Thalassaemia Unit, General Hospital of Corinth
Hypothesis
What happens to iron levels in pregnant women with transfusion-dependent thalassemia when iron chelation therapy is stopped?
Conclusion
The study shows that stopping iron chelation therapy during pregnancy can lead to rapid iron overload in women with transfusion-dependent thalassemia.
Supporting Evidence
- The patient's ferritin level rose from 67 μg/L before pregnancy to 1583 μg/L after delivery.
- Her liver iron concentration increased from 1 mg/g dry weight to 11.3 mg/g dry weight during the same period.
- Cardiac function remained normal but showed a downward trend in T2* values.
Takeaway
If a woman with thalassemia stops her iron treatment during pregnancy, she can quickly get too much iron in her body, which can be dangerous.
Methodology
The patient was monitored before and after pregnancy to assess the impact of stopping chelation therapy for 12 months.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
The patient was a 38-year-old woman with transfusion-dependent thalassemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website